{"id":"W3083593114","doi":"10.1136/ijgc-2020-001694","title":"DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Medicine; Tolerability; Epithelial ovarian cancer; Oncology; Internal medicine; Ovarian cancer; Randomized controlled trial; Maintenance therapy; Phases of clinical research; Gynecology; Clinical trial; Cancer; Chemotherapy; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003940854,0.001952136,0.003291964,0.0004558097,0.0006987109,0.001417762,0.001373578,0.002282952,0.008825309],"category_scores_gemma":[0.002717494,0.0008476946,0.002286055,0.0004679048,0.001326163,0.002075126,0.0008082761,0.003219857,0.001048418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009910639,"about_ca_system_score_gemma":0.002005179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006528097,"about_ca_topic_score_gemma":0.001965903,"domain_scores_codex":[0.9989265,0.0006284442,0.00005968805,0.0001776921,0.00008223403,0.000125449],"domain_scores_gemma":[0.9981424,0.0004378458,0.0004943835,0.0001671628,0.0001138832,0.0006443934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9608331,0.01810681,0.001706634,0.0006152715,0.0007989104,0.00006508442,0.0000745717,0.0003164645,0.004564591,0.0001264753,0.001158793,0.01163335],"study_design_scores_gemma":[0.9068246,0.08996491,0.001874696,0.00001856262,0.0001924482,0.00004711592,0.00001223936,0.0002071237,0.0002011439,0.00006231116,0.0005847536,0.00001012017],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9756352,0.003692785,0.0009611722,0.001124284,0.0005896206,0.01285503,0.00267389,0.0001444133,0.002323516],"genre_scores_gemma":[0.9561801,0.002198661,0.004127982,0.002801293,0.0008885822,0.02439081,0.004493296,0.00004529114,0.004873867],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.008825309,"threshold_uncertainty_score":0.02952355,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02405044085055702,"score_gpt":0.3140832839292023,"score_spread":0.2900328430786452,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}